E is for Endpoint II: How to Implement the Vital Layers on Your Endpoints

Expansion of stem cells and some primary cells requires either animal-origin components in culture media or coating of the culture vessels with human or animal-derived extracellular matrix (ECM) protein. Growing concerns about introducing human and animal-derived pathogens into the culture necessitate the need for animal- free (xeno-free and human-origin components-free) culture environment. Herein, we present defined and synthetic surfaces for cell culture. Corning® PureCoat™ ECM Mimetic cultureware collagen I peptide and fibronectin peptide support culture of cell types requiring collagen I or fibronectin protein -coated surfaces. Corning Synthemax® surface consists of a vitronectin peptide and supports undifferentiated expansion of human pluripotent stem cells (hPSC) and neural progenitor cells (NPCs). ECM Mimetic and Synthemax cultureware are pre-coated, synthetic, animal-free, and room temperature stable. Synthemax-SC is available for self-coating.

We demonstrate expansion and functionality of several clinically relevant cell types including hPSCs (human embryonic stem cells and induced pluripotent stem cells), MSCs, human keratinocytes (HKN), endothelial colony forming cells (ECFCs), NPCs and cell lines for bio manufacturing (CHO and Vero) on these surfaces. Corning Synthemax and ECM mimetic cultureware are versatile surfaces compatible with multiple media for culture of various cell types providing a ready to use alternative to ECM coating where animal-free and defined conditions are desirable.

Learn about new features coming with SharePoint 2013 including changes in Service Applications and improvements in SQL and Storage, as well as social computing and collaboration with Profile Synchronization improvements. Our SharePoint experts will also share best practices for managing your SharePoint customizations including utilizing SharePoint-hosted apps and SharePoint management team development.

With the impending patent expiries of biologic drugs, there is a huge market potential for subsequent entry biologics. A strong integration of R&D and marketing is key to success, and this briefing will highlight the technology advancements.

Why you should attend:
·Learn about the growth of follow-on-biologics
·Identify the drivers and restraints
·Discuss trends in technology development

Join Raj for a complete regulatory overview including:

- HIPAA Omnibus Update
- FTC Health Breach Rule
- Top 5 reasons organizations FAIL Security Assessments
- Case Studies
- Guidance
- Success Stories

The HITECH Act created new categories of business associates that included health information organizations (HIO), these days referred to as HIEs, and health insurance exchanges (HIX). OCR is preparing to make sure these business associates follow the HIPAA rules.

The omnibus rule compliance date is rapidly approaching. If you’re an HIE or an HIX, it’s time to make sure all of those policies are in place, the workforce is trained and all of those other tasks that pave the road to HIPAA compliance. This also includes, among other things, reaching out to all of your covered entity customers and negotiating that business associate agreement, testing security incident response plans and that business continuity plan. You will walk away with a solid understanding of the not-so-new privacy and security requirements and practical information you can use to ramp up your compliance efforts in preparation for the September 23, 2013 omnibus rule compliance deadline.

The Lazy Attacker: Defending Against Broad-based Cyber Attacks with Unified & Collaborative Defenses

Advanced Persistent Attacks (APTs) get most of the attention from the cyber security community because, as defenders, we want to be vigilant against the most insidious techniques. However, this unilateral mindset ignores a much less interesting reality. Generally, cyber criminals are as lazy as criminals in the “real world.” What do we mean by lazy? Attackers will use the “lowest common denominator” method against the widest range of IP addresses from the same source set of IP addresses - which means that sharing information about their methods with others, and implementing simple defenses are best practices.

Adjusting your focus from the “shiny object” of APTs to those broad-based threats can help prioritize your own defenses and optimize your incident response program. Attend this webinar to hear directly from Jaime Blasco, Director of AlienVault Labs, on how you can:

* Understand the common exploit methods of the “lazy attacker”
* Review the benefits of a collaborative approach to threat intelligence
* Prioritize defensive tactics and remediation activities
* Implement a unified, simplified approach to threat management

This is the second in a series of three webinars covering the topic Value based healthcare.

The session will cover:

•The benefits of considering value in healthcare and the opportunities for organisations
•Examples from provider organisations who have a adopted a value approach
•The challenges with adopting a different approach and how to engage teams/the wider organisation in the vale agenda
•The role of medics and clinical teams in supporting the change
•The impact of adopting this approach
•Opportunities for the future

Recent studies have shown that at least 20% of the animal cell cultures currently in use in the US are contaminated by either microorganisms or other cell lines. This three part live, on-line seminar series will review the scope of this major problem and examine some of its causes and techniques for avoiding it. It will also explore some key, easy to employ strategies for preventing these losses by careful culture management.

This webinar will discuss good aseptic technique: developing a practical approach to aseptic technique; reducing day-to-day contamination problems in the lab; and helpful hints for avoiding contamination.

This free webinar will address the key issues that all finance staff will need to consider during these challenging and changing times in the NHS. It is vital to be prepared, both personally and professionally even if you are not currently directly affected by change, it is important to keep one step ahead. Don't miss this opportunity to learn and understand more about the NHS reforms and current context.

We are delighted to announce that Paul Taylor, Interim Director of Finance, Royal Orthopaedic Hospital FT, will lead this session giving you a clear picture and national perspective of the current key issues and priorities across the NHS.

This webinar will be an hour long and will consist of the presentation followed by a question and answer session, which will allow you to pose your questions to the facilitator.

Are you facing any of these situations?

• You’ve bought BPM technology, but are not sure how or where to get started?

• You got off to the wrong foot on BPM processes. Now how do you fix that?

• You’ve done process modeling of the As-Is processes? What do you do next?


Join us for an insightful and informative look at how to get started on the right path, and how to quickly correct if you didn’t, with Business Process Management.

This workshop will address these three use cases and help you figure out what to next. For each scenario, the workshop will address:

1. What’s most important here?
2. How do you engage executive sponsorship in the discussion and gain their commitment?
3. How can metrics help us make the point?

Learn best practices to get off to the right start. Use practitioner tips to refocus your BPM effort. Select and engage the right executive sponsor and process owner for support and success. Use joint model-driven process models to provide momentum for the BPM efforts.